OAG 015 – August 2017 Related Content
Wood: reducing the impacts of harsh weather
Herje Bojström, CEO of Sioo Wood Protection AB in Sweden highlights the benefits of protection systems to reduce the impact that weather has on wood.
Therapies for weak muscles
Research into personalised interventions is helping pave the way for a new generation of therapies for weak muscles at the Balgrist Campus
It is estimated that ten percent of the costs of health care in Switzerland (or an equivalent of 500 billion Euros per annum in the EU) being associated...
Understanding the process of intravenous access
Virginia M Stewart, MD outlines when intravenous access may be needed and how the skilful process should be undertaken
Understanding the characterisation of sustainable materials
Moniek Tromp, Van t Hoff Institute for Molecular Sciences, Sustainable Materials Characterisation sheds light on sustainable materials and their benefits
Disease-associated myosteatosis in people with cancer: Can it be treated?
Can we prevent the muscle loss associated with some cancers? Dr Vera Mazurak at the University of Alberta is looking into one method of treating myosteatosis
Pathological fat infiltration into muscle is a feature of disease-induced muscle loss that significantly associates with shorter survival in people with cancer. Fat is...
How do we build safer digital environments?
Identify, Protect, Defend, Respond are the four key components to ensure safer digital environments. Here, Fujitsu provide insight
Time for a change of tack on drug development for neurodegenerative diseases?
UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's
Neurodegenerative diseases are a growing global challenge, as medical advances ensure more individuals live longer. By 2020 there will be more than 40 million people in the world...
The Smart City Charter and the missing link to climate resilience
Prof Dr Daniela Jacob, Climate Service Centre Germany, highlights the Smart City Charter and what it means for the future of cities
The evolution of malaria drug development
David H Peyton at Portland State University outlines how research has discovered that heme is key to malaria drug development
Asset management must be a consideration for the rail sector
During holiday season asset management is very important to the rail industry. Here, Marcel Van Velthoven, CEO of ZNAPZ explains why
PAN-LNG Project: Developing Trans-European transport in Hungary
With funding from the Connecting Europe Facility, the PAN-LNG Project is developing a Trans-European transport infrastructure, starting in Hungary
MGKKE, the Hungarian NGV Association, developed the PAN-LNG Project for the liquefied natural gas (LNG) fuelling infrastructure, which has been selected in 2015 for co-finance by the INEA under the Connecting...
Sustainability through technology: The power of N
Popularism and bumper sticker science should not stop us tackling sustainability through technology, argues Ingenuity Lab Director Carlo Montemagno
Ingenuity Lab is a unique organisation, designed and created to solve many of the grand challenges facing a modern world. Ingenuity Lab is a research organisation that focuses on the development...
An insight into Escherichia coli
Understanding Escherichia coli ecology and evolution in the gut as a commensal is a prerequisite to fight this opportunistic pathogen
Understanding cancer through molecular cell biology
Progress in Targeted Therapy and Immunotherapy of Cancer Requires Rethinking of European Reimbursement Practices for Mutation Testing
Focusing on paediatric cancers
Epigenetic changes play a critical role in the development of paediatric cancers. Ivan Stamenkovic, Professor of Pathology, explains
Biomedical research: crossing discipline borders
Biomedical research crosses borders of disciplines to help shape new imaging approaches, as scientists from Technical University of Munich explain
Environmental chemicals: factors for neurodevelopmental disorders?
Pamela Lein, University of California, looks at whether environmental chemicals influence individual risk for the diagnosis of neurodevelopmental disorders
Adaptive clinical trials: Ethical and efficient
Prof Thomas Jaki at the Medical and Pharmaceutical Statistics Research Unit, Lancaster University outlines the benefits of adaptive clinical trials
Understanding the adverse outcome pathway concept
Alberto Mantovani, Istituto Superiore di Sanità looks at how the adverse outcome pathway concept is the long way from molecular to adversity
Queueing theory: the solution to unsustainable wait list practices
David Stanford, Richard Boucherie, and Peter Taylor outline how queueing theory could help tackle some of the challenges in the healthcare sector